Sector consensus Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 2025-01-24			5-day change	1st Jan Change
180,200.00 ^KRW	+0.61%		-0.99%	-3.89%

Jan. 23	Celltrion Launches SteQeyma Across Five European Countries	MT
Jan. 14	Celltrion Unveils Strategic Vision for Advancing Its Innovative Drug Pipeline At the 43Rd Annual J.P. Morgan Healthcare Conference	CI

Sector:

Location:

X axis:

Main competitors

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
CELLTRION, INC.	236,564.63	+32.09%	21
LONZA GROUP AG	636.81	+9.19%	21
IQVIA HOLDINGS INC.	249.04	+20.89%	24
ICON PUBLIC LIMITED COMPANY	259.88	+28.22%	17
UNITED THERAPEUTICS CORPORATION	398.00	+7.02%	14
MODERNA, INC.	68.01	+60.43%	22
BIO-TECHNE CORPORATION	85.26	+10.86%	13
MEDPACE HOLDINGS, INC.	343.03	-1.40%	10
QIAGEN N.V.	51.14	+11.60%	17
TEMPUS AI, INC	56.89	+3.74%	9
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	199.51	+19.57%	18
REVOLUTION MEDICINES, INC.	73.43	+78.48%	14
BLUEPRINT MEDICINES CORPORATION	125.47	+8.51%	19
TELIX PHARMACEUTICALS LIMITED	24.77	-7.89%	8
PHARMARON BEIJING CO., LTD.	28.90	+15.15%	11
IONIS PHARMACEUTICALS, INC.	61.32	+77.94%	25
HANGZHOU TIGERMED CONSULTING CO., LTD	61.04	+26.09%	17
ALKERMES PLC	34.08	+7.33%	13
BACHEM HOLDING AG	76.00	+29.58%	7
Average	12,599.85	+23.02%	16
Weighted average by Cap.	24,582.44	+21.42%	18